Escherichia coli CIP 106046 is a facultative anaerobe, Gram-negative, motile bacterium of the family Enterobacteriaceae.
Gram-negative motile rod-shaped facultative anaerobe genome sequence Bacteria| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Enterobacterales |
| Family Enterobacteriaceae |
| Genus Escherichia |
| Species Escherichia coli |
| Full scientific name Escherichia coli (Migula 1895) Castellani and Chalmers 1919 (Approved Lists 1980) |
| Synonyms (1) |
| @ref | Gram stain | Cell shape | Motility | |
|---|---|---|---|---|
| 39452 | negative | rod-shaped |
| @ref | Name | Growth | Composition | Medium link | |
|---|---|---|---|---|---|
| 39452 | MEDIUM 29- Brain heart agar | Distilled water make up to (1000.000 ml);Brain heart infusion agar (52.000 g) | |||
| 39452 | CIP Medium 29 | Medium recipe at CIP |
| 39452 | Oxygen tolerancefacultative anaerobe |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68371 | 27613 ChEBI | amygdalin | - | builds acid from | from API 50CH acid |
| 68371 | 18305 ChEBI | arbutin | - | builds acid from | from API 50CH acid |
| 68371 | 17057 ChEBI | cellobiose | - | builds acid from | from API 50CH acid |
| 39452 | 16947 ChEBI | citrate | - | carbon source | |
| 68371 | 18333 ChEBI | D-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 15824 ChEBI | D-fructose | + | builds acid from | from API 50CH acid |
| 68371 | 28847 ChEBI | D-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 12936 ChEBI | D-galactose | + | builds acid from | from API 50CH acid |
| 68371 | 17634 ChEBI | D-glucose | + | builds acid from | from API 50CH acid |
| 68371 | 62318 ChEBI | D-lyxose | - | builds acid from | from API 50CH acid |
| 68371 | 16899 ChEBI | D-mannitol | + | builds acid from | from API 50CH acid |
| 68371 | 16024 ChEBI | D-mannose | + | builds acid from | from API 50CH acid |
| 68371 | 16988 ChEBI | D-ribose | + | builds acid from | from API 50CH acid |
| 68371 | 17924 ChEBI | D-sorbitol | + | builds acid from | from API 50CH acid |
| 68371 | 16443 ChEBI | D-tagatose | - | builds acid from | from API 50CH acid |
| 68371 | 65327 ChEBI | D-xylose | + | builds acid from | from API 50CH acid |
| 68371 | 17113 ChEBI | erythritol | - | builds acid from | from API 50CH acid |
| 39452 | 4853 ChEBI | esculin | - | hydrolysis | |
| 68371 | 4853 ChEBI | esculin | - | builds acid from | from API 50CH acid |
| 68371 | 16813 ChEBI | galactitol | + | builds acid from | from API 50CH acid |
| 68371 | 28066 ChEBI | gentiobiose | - | builds acid from | from API 50CH acid |
| 68371 | 24265 ChEBI | gluconate | + | builds acid from | from API 50CH acid |
| 39452 | 17234 ChEBI | glucose | + | fermentation | |
| 39452 | 17234 ChEBI | glucose | + | degradation | |
| 68371 | 17754 ChEBI | glycerol | + | builds acid from | from API 50CH acid |
| 68371 | 28087 ChEBI | glycogen | - | builds acid from | from API 50CH acid |
| 68371 | 15443 ChEBI | inulin | - | builds acid from | from API 50CH acid |
| 68371 | 30849 ChEBI | L-arabinose | + | builds acid from | from API 50CH acid |
| 68371 | 18403 ChEBI | L-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 18287 ChEBI | L-fucose | + | builds acid from | from API 50CH acid |
| 68371 | 62345 ChEBI | L-rhamnose | + | builds acid from | from API 50CH acid |
| 68371 | 17266 ChEBI | L-sorbose | + | builds acid from | from API 50CH acid |
| 68371 | 65328 ChEBI | L-xylose | - | builds acid from | from API 50CH acid |
| 39452 | 17716 ChEBI | lactose | + | fermentation | |
| 68371 | 17716 ChEBI | lactose | + | builds acid from | from API 50CH acid |
| 39452 | 15792 ChEBI | malonate | - | assimilation | |
| 68371 | 17306 ChEBI | maltose | + | builds acid from | from API 50CH acid |
| 39452 | 29864 ChEBI | mannitol | + | fermentation | |
| 68371 | 6731 ChEBI | melezitose | - | builds acid from | from API 50CH acid |
| 68371 | 28053 ChEBI | melibiose | + | builds acid from | from API 50CH acid |
| 68371 | 320061 ChEBI | methyl alpha-D-glucopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 43943 ChEBI | methyl alpha-D-mannoside | - | builds acid from | from API 50CH acid |
| 68371 | 74863 ChEBI | methyl beta-D-xylopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 17268 ChEBI | myo-inositol | - | builds acid from | from API 50CH acid |
| 68371 | 59640 ChEBI | N-acetylglucosamine | + | builds acid from | from API 50CH acid |
| 39452 | 17632 ChEBI | nitrate | + | reduction | |
| 39452 | 16301 ChEBI | nitrite | + | reduction | |
| 68371 | Potassium 2-ketogluconate | - | builds acid from | from API 50CH acid | |
| 68371 | Potassium 5-ketogluconate | + | builds acid from | from API 50CH acid | |
| 68371 | 16634 ChEBI | raffinose | + | builds acid from | from API 50CH acid |
| 68371 | 15963 ChEBI | ribitol | - | builds acid from | from API 50CH acid |
| 68371 | 17814 ChEBI | salicin | - | builds acid from | from API 50CH acid |
| 39452 | 132112 ChEBI | sodium thiosulfate | - | builds gas from | |
| 68371 | 28017 ChEBI | starch | - | builds acid from | from API 50CH acid |
| 68371 | 17992 ChEBI | sucrose | + | builds acid from | from API 50CH acid |
| 68371 | 27082 ChEBI | trehalose | + | builds acid from | from API 50CH acid |
| 68371 | 32528 ChEBI | turanose | - | builds acid from | from API 50CH acid |
| 68371 | 17151 ChEBI | xylitol | - | builds acid from | from API 50CH acid |
| @ref | Metabolite | Is sensitive | Is resistant | |
|---|---|---|---|---|
| 39452 | 0129 (2,4-Diamino-6,7-di-iso-propylpteridine phosphate) |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 39452 | alcohol dehydrogenase | - | 1.1.1.1 | |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | + | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | + | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 68382 | beta-galactosidase | + | 3.2.1.23 | from API zym |
| 39452 | beta-galactosidase | + | 3.2.1.23 | |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 39452 | catalase | + | 1.11.1.6 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | - | from API zym | |
| 39452 | gelatinase | - | ||
| 68382 | leucine arylamidase | + | 3.4.11.1 | from API zym |
| 68382 | lipase (C 14) | - | from API zym | |
| 39452 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | - | from API zym | |
| 39452 | ornithine decarboxylase | + | 4.1.1.17 | |
| 39452 | oxidase | - | ||
| 39452 | phenylalanine ammonia-lyase | - | 4.3.1.24 | |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 39452 | tryptophan deaminase | - | ||
| 39452 | urease | - | 3.5.1.5 | |
| 68382 | valine arylamidase | - | from API zym |
| @ref | ControlQ | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39452 | not determinedn.d. | + | - | +/- | + | + | + | - | - | - | + | + | + | + | + | + | + | - | + | + | - | - | + | - | - | - | - | - | + | + | + | + | + | - | - | + | - | - | - | - | - | - | - | - | + | - | - | + | - | + |
| @ref | Biosafety level | Biosafety level comment | |
|---|---|---|---|
| 39452 | 2 | Risk group (French classification) |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Biotechnology | Engineering bispecific HER2xVEGF designed ankyrin repeat proteins for targeted nanobiotechnology applications. | Chen F, Bradbury MS. | J Nanobiotechnology | 10.1186/s12951-025-03631-4 | 2025 | |
| Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment-Drug Conjugates (FDCs). | Jolivet L, Ait Mohamed Amar I, Horiot C, Boursin F, Colas C, Letast S, Denevault-Sabourin C, Allard-Vannier E, Joubert N, Aubrey N. | Pharmaceutics | 10.3390/pharmaceutics14081524 | 2022 | ||
| [Assessment of available and currently applied typing methods including genome-based methods for zoonotic pathogens with a focus on Salmonella enterica]. | Pietsch M, Simon S, Richter A, Malorny B, Uelze L, Hepner S, Dangel A, Sing A, Huber I, Busch U, Linde J, Methner U, Becker N, Werner G, Mellmann A, Fruth A, Flieger A. | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | 10.1007/s00103-022-03622-y | 2023 | ||
| Affibody-Derived Drug Conjugates Targeting HER2: Effect of Drug Load on Cytotoxicity and Biodistribution. | Ding H, Xu T, Zhang J, Tolmachev V, Oroujeni M, Orlova A, Graslund T, Vorobyeva A. | Pharmaceutics | 10.3390/pharmaceutics13030430 | 2021 | ||
| Pathogenicity | Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. | Panjideh H, Niesler N, Weng A, Fuchs H. | Toxins (Basel) | 10.3390/toxins14070478 | 2022 | |
| [Current practice of empiric antibiotic treatment for spondylodiscitis]. | Lang S, Walter N, Neumann C, Bartl S, Simon M, Ehrenschwender M, Hitzenbichler F, Alt V, Rupp M. | Orthopadie (Heidelb) | 10.1007/s00132-022-04240-x | 2022 | ||
| Röntgenuntersuchungen des Thorax bei Kindern und Jugendlichen : Indikationen und Limitationen Chest X-rays in children and adolescentsIndications and limitations | Renz D, Huisinga C, Pfeil A, Bottcher J, Schwerk N, Streitparth F, Weidemann J. | Zeitschrift Für Pneumologie | 2022 | |||
| [Chest X-rays in children and adolescents : Indications and limitations]. | Renz DM, Huisinga C, Pfeil A, Bottcher J, Schwerk N, Streitparth F, Weidemann J. | Radiologe | 10.1007/s00117-021-00954-9 | 2022 | ||
| Genetic evidence for a regulated cysteine protease catalytic triad in LegA7, a Legionella pneumophila protein that impinges on a stress response pathway. | Hershkovitz D, Chen EJ, Ensminger AW, Dugan AS, Conway KT, Joyce AC, Segal G, Isberg RR. | mSphere | 10.1128/msphere.00222-24 | 2024 | ||
| Enzymology | Vibrio cholerae non-O1 - the first reported case of keratitis in a healthy patient. | Chen WD, Lai LJ, Hsu WH, Huang TY. | BMC Infect Dis | 10.1186/s12879-019-4475-4 | 2019 | |
| Rabbit derived VL single-domains as promising scaffolds to generate antibody-drug conjugates. | Andre AS, Dias JNR, Aguiar S, Nogueira S, Bule P, Carvalho JI, Antonio JPM, Cavaco M, Neves V, Oliveira S, Vicente G, Carrapico B, Braz BS, Rutgen B, Gano L, Correia JDG, Castanho M, Goncalves J, Gois PMP, Gil S, Tavares L, Aires-da-Silva F. | Sci Rep | 10.1038/s41598-023-31568-x | 2023 | ||
| Applications of SNAP-tag technology in skin cancer therapy. | Padayachee ER, Adeola HA, Van Wyk JC, Nsole Biteghe FA, Chetty S, Khumalo NP, Barth S. | Health Sci Rep | 10.1002/hsr2.103 | 2019 | ||
| [Diagnosis and therapy of granulomatosis with polyangiitis and microscopic polyangiitis-2023: consensus of the Austrian society of nephrology (ÖGN) and Austrian society of rheumatology (ÖGR)]. | Odler B, Windpessl M, Eller K, Saemann MD, Lhotta K, Neumann I, Oberseder G, Duftner C, Dejaco C, Rudnicki M, Gauckler P, Hintenberger R, Zwerina J, Thiel J, Kronbichler A. | Wien Klin Wochenschr | 10.1007/s00508-023-02262-9 | 2023 | ||
| Acute kidney injury in dogs: Etiology, clinical and clinicopathologic findings, prognostic markers, and outcome. | Rimer D, Chen H, Bar-Nathan M, Segev G. | J Vet Intern Med | 10.1111/jvim.16375 | 2022 | ||
| [Recombinant allergens, peptides, and virus-like particles for allergy immunotherapy]. | Holzhauser T, Schuler F, Dudek S, Kaul S, Vieths S, Mahler V. | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | 10.1007/s00103-020-03231-7 | 2020 | ||
| Metabolism | L-lysine catabolism is controlled by L-arginine and ArgR in Pseudomonas aeruginosa PAO1. | Chou HT, Hegazy M, Lu CD. | J Bacteriol | 10.1128/jb.00673-10 | 2010 | |
| Methods to Make Homogenous Antibody Drug Conjugates. | Kline T, Steiner AR, Penta K, Sato AK, Hallam TJ, Yin G. | Pharm Res | 10.1007/s11095-014-1596-8 | 2015 | ||
| Enzymology | Fickle or Faithful: The Roles of Host and Environmental Context in Determining Symbiont Composition in Two Bathymodioline Mussels. | Laming SR, Szafranski KM, Rodrigues CF, Gaudron SM, Cunha MR, Hilario A, Le Bris N, Duperron S. | PLoS One | 10.1371/journal.pone.0144307 | 2015 | |
| Voltage-gated Na+ Channel Activity Increases Colon Cancer Transcriptional Activity and Invasion Via Persistent MAPK Signaling. | House CD, Wang BD, Ceniccola K, Williams R, Simaan M, Olender J, Patel V, Baptista-Hon DT, Annunziata CM, Gutkind JS, Hales TG, Lee NH. | Sci Rep | 10.1038/srep11541 | 2015 | ||
| Metabolism | Functional characterization of seven gamma-Glutamylpolyamine synthetase genes and the bauRABCD locus for polyamine and beta-Alanine utilization in Pseudomonas aeruginosa PAO1. | Yao X, He W, Lu CD. | J Bacteriol | 10.1128/jb.05105-11 | 2011 | |
| Genetic analysis of dar, uvsW, and uvsY in bacteriophage T4: dar and uvsW are alleles. | Wu JR, Yeh YC, Ebisuzaki K. | J Virol | 10.1128/jvi.52.3.1028-1031.1984 | 1984 | ||
| Metabolism | Nonclassical protein secretion by Bacillus subtilis in the stationary phase is not due to cell lysis. | Yang CK, Ewis HE, Zhang X, Lu CD, Hu HJ, Pan Y, Abdelal AT, Tai PC. | J Bacteriol | 10.1128/jb.05897-11 | 2011 | |
| Metabolism | The arginine regulatory protein mediates repression by arginine of the operons encoding glutamate synthase and anabolic glutamate dehydrogenase in Pseudomonas aeruginosa. | Hashim S, Kwon DH, Abdelal A, Lu CD. | J Bacteriol | 10.1128/jb.186.12.3848-3854.2004 | 2004 | |
| Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development. | Agarwal P, Bertozzi CR. | Bioconjug Chem | 10.1021/bc5004982 | 2015 | ||
| Metabolism | Regulation and characterization of the dadRAX locus for D-amino acid catabolism in Pseudomonas aeruginosa PAO1. | He W, Li C, Lu CD. | J Bacteriol | 10.1128/jb.00036-11 | 2011 | |
| Metabolism | The multifaceted proteins MvaT and MvaU, members of the H-NS family, control arginine metabolism, pyocyanin synthesis, and prophage activation in Pseudomonas aeruginosa PAO1. | Li C, Wally H, Miller SJ, Lu CD. | J Bacteriol | 10.1128/jb.00888-09 | 2009 | |
| Metabolism | Analysis of lambda insertions in the fucose utilization region of Escherichia coli K-12: use of lambda fuc and lambda argA transducing bacteriophages to partially order the fucose utilization genes. | Skjold AC, Ezekiel DH. | J Bacteriol | 10.1128/jb.152.1.120-125.1982 | 1982 | |
| Metabolism | The ArgR regulatory protein, a helper to the anaerobic regulator ANR during transcriptional activation of the arcD promoter in Pseudomonas aeruginosa. | Lu CD, Winteler H, Abdelal A, Haas D. | J Bacteriol | 10.1128/jb.181.8.2459-2464.1999 | 1999 | |
| Metabolism | Functional analysis and regulation of the divergent spuABCDEFGH-spuI operons for polyamine uptake and utilization in Pseudomonas aeruginosa PAO1. | Lu CD, Itoh Y, Nakada Y, Jiang Y. | J Bacteriol | 10.1128/jb.184.14.3765-3773.2002 | 2002 | |
| Recalibrated linkage map of Escherichia coli K-12. | Bachmann BJ, Low KB, Taylor AL. | Bacteriol Rev | 10.1128/br.40.1.116-167.1976 | 1976 | ||
| Revised linkage map of Escherichia coli. | Taylor AL, Trotter CD. | Bacteriol Rev | 10.1128/br.31.4.332-353.1967 | 1967 | ||
| Linkage map of Escherichia coli K-12, edition 10: the traditional map. | Berlyn MK. | Microbiol Mol Biol Rev | 10.1128/mmbr.62.3.814-984.1998 | 1998 | ||
| New late gene, dar, involved in the replication of bacteriophage T4 DNA. II. Overproduction of DNA binding protein (gene 32 protein) and further characterization. | Wu JR, Yeh YC. | J Virol | 10.1128/jvi.27.1.90-102.1978 | 1978 | ||
| Vesicle-enriched secretomes alter bacterial competitive abilities and are drivers of evolution in microbial communities. | Warsi OM, Gedda L, Edwards K, Andersson DI. | FEMS Microbiol Ecol | 10.1093/femsec/fiad141 | 2023 | ||
| Pathogenicity | Enterobacteria Phage SV76 Host Range and Genomic Characterization. | Carmody CM, Farquharson EL, Nugen SR. | Phage (New Rochelle) | 10.1089/phage.2022.0005 | 2022 | |
| Pathogenicity | Enterobacteria Phage Ac3's Genome Annotation and Host Range Analysis Against the ECOR Reference Library. | Farquharson EL, Nugen SR. | Phage (New Rochelle) | 10.1089/phage.2022.0008 | 2022 | |
| Genome evolution and the emergence of pathogenicity in avian Escherichia coli. | Mageiros L, Meric G, Bayliss SC, Pensar J, Pascoe B, Mourkas E, Calland JK, Yahara K, Murray S, Wilkinson TS, Williams LK, Hitchings MD, Porter J, Kemmett K, Feil EJ, Jolley KA, Williams NJ, Corander J, Sheppard SK. | Nat Commun | 10.1038/s41467-021-20988-w | 2021 | ||
| Heavy Metal Susceptibility of Escherichia coli Isolated from Urine Samples from Sweden, Germany, and Spain. | Sutterlin S, Tellez-Castillo CJ, Anselem L, Yin H, Bray JE, Maiden MCJ. | Antimicrob Agents Chemother | 10.1128/aac.00209-18 | 2018 | ||
| Genetics | Phenotype inference in an Escherichia coli strain panel. | Galardini M, Koumoutsi A, Herrera-Dominguez L, Cordero Varela JA, Telzerow A, Wagih O, Wartel M, Clermont O, Denamur E, Typas A, Beltrao P. | Elife | 10.7554/elife.31035 | 2017 | |
| CRISPR Diversity in E. coli Isolates from Australian Animals, Humans and Environmental Waters. | Sheludchenko MS, Huygens F, Stratton H, Hargreaves M. | PLoS One | 10.1371/journal.pone.0124090 | 2015 | ||
| Natural DNA uptake by Escherichia coli. | Sinha S, Redfield RJ. | PLoS One | 10.1371/journal.pone.0035620 | 2012 | ||
| Metabolism | Osmoregulatory systems of Escherichia coli: identification of betaine-carnitine-choline transporter family member BetU and distributions of betU and trkG among pathogenic and nonpathogenic isolates. | Ly A, Henderson J, Lu A, Culham DE, Wood JM. | J Bacteriol | 10.1128/jb.186.2.296-306.2004 | 2004 | |
| Phylogeny | Rapid and simple determination of the Escherichia coli phylogenetic group. | Clermont O, Bonacorsi S, Bingen E. | Appl Environ Microbiol | 10.1128/aem.66.10.4555-4558.2000 | 2000 | |
| The ETT2 gene cluster, encoding a second type III secretion system from Escherichia coli, is present in the majority of strains but has undergone widespread mutational attrition. | Ren CP, Chaudhuri RR, Fivian A, Bailey CM, Antonio M, Barnes WM, Pallen MJ. | J Bacteriol | 10.1128/jb.186.11.3547-3560.2004 | 2004 | ||
| Diversity and host range of Shiga toxin-encoding phage. | Gamage SD, Patton AK, Hanson JF, Weiss AA. | Infect Immun | 10.1128/iai.72.12.7131-7139.2004 | 2004 | ||
| Bacterial interspersed mosaic elements (BIMEs) are a major source of sequence polymorphism in Escherichia coli intergenic regions including specific associations with a new insertion sequence. | Bachellier S, Clement JM, Hofnung M, Gilson E. | Genetics | 10.1093/genetics/145.3.551 | 1997 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #39452 | Collection of Institut Pasteur ; Curators of the CIP; CIP 106046 |
| #68371 | Automatically annotated from API 50CH acid . |
| #68382 | Automatically annotated from API zym . |
| #124043 | Isabel Schober, Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive138317.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data